Medical/Pharmaceuticals

Review of Myopia Management and Plano Announce New Content Partnership

SINGAPORE, April 6, 2021 /PRNewswire/ -- Review of Myopia Management  (RMM) is pleased to announce a new partnership with theSingapore-based Healthtech company, Plano Pte Ltd . Under their new agreement,RMM and Plano will produce new educational con...

2021-04-06 11:00 5473

Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma

SHANGHAI and HONG KONG, April 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-04-06 08:00 10266

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

* Crossover allows participants to continue in trials and remain blinded * Ensures that all trial participants receive active vaccine * South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned GAITHERSBURG, Md., April 6, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...

2021-04-06 05:00 6971

AI-Based Imaging Analysis Tools and Cloud-Based Deployments to Bolster the Global Digital Pathology Market

SANTA CLARA, Calif., April 5, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market, finds that this market is estimated to hit $825.9 million by 2025 from $513.3 million in 2019 at a compoun...

2021-04-05 18:03 3691

Pfizer collaborates with DoctorOnCall to improve health literacy and patient care in Malaysia

KUALA LUMPUR, Malaysia, April 5, 2021 /PRNewswire/ -- Pfizer today announced its collaboration with DoctorOnCall to launch a digital therapeutics platform that focuses on three key therapeutic areas namely smoking cessation, vaccination, and heart health. Catering to an increasingly tech-savvy an...

2021-04-05 11:32 20466

Ascentage Pharma Appoints Renowned Oncologist Dr. David Sidransky, MD, to its Board as an Independent Non-Executive Director

SUZHOU, China and ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its appointment of Dr.David ...

2021-04-02 19:39 5685

US FDA Approved Jemincare to Initiate Clinical Trial of Neutralizing Antibody JMB2002

SHANGHAI, April 2, 2021 /PRNewswire/ -- On March 31, 2021, Jemincare group announced that their anti-SARS-CoV-2 neutralizing antibody, JMB2002, independently developed by Jemincare Shanghai Research Center, was approved by FDA for clinical trial inthe United States. Preclinical data showed that ...

2021-04-02 13:40 4591

Regent Pacific Receives HK$24.96 million After Clinical Trial Approval For FORTACIN(TM) Has Been Obtained

HONG KONG, April 1, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that the Group has received a...

2021-04-01 21:11 3652

Neurophth Announces IND Approval by the NMPA for Leber Hereditary Optic Neuropathy Gene Therapy

WUHAN and SUZHOU, China, April 1, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company developing adeno-associated viral (AAV)-delivered gene therapies for the treatment of ocular diseases, recently announced the Center for Drug Evaluation (CDE) of China...

2021-04-01 20:39 5651

LimaCorporate Announces the Successful Completion of the First Total Shoulder Arthroplasty Using the Smart Space Cubit Intraoperative Guidance System

SAN DANIELE DEL FRIULI, Italy, April 1, 2021 /PRNewswire/ -- LimaCorporate achieves an important landmark in the development of its digital platform designed to assist surgeons in delivering improved outcomes with an accessible and sustainable economic model, following the milestone-based acquisi...

2021-04-01 20:00 1929

Molecular Data Inc. intends to further upgrade its digital tools using Blockchain

SHANGHAI, April 1, 2021 /PRNewswire/ -- Molecular Data Inc. ("Molecular Data" or the "Company") (Nasdaq: MKD), a leading technology-driven platform inChina's chemical industry, announced that it has signed a cooperation agreement with Dalian Lianhua Chemical Co., Ltd. ("Dalian Lianhua"), a leadin...

2021-04-01 19:00 2937

Ping An AskBob Doctor's Smart Imaging Model for Diagnosis of Pelvic and Hip Injuries is a Breakthrough for Artificial Intelligence

HONG KONG and SHANGHAI, April 1, 2021 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318; SSE: 601318) is pleased to announce that Ping An AskBob Doctor's smart imaging model for diagnosing pelvic and hip injuries is the first of its ki...

2021-04-01 17:17 3080

Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists

TOKYO, April 1, 2021 /PRNewswire/ -- Leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digital therapeutics (hereinafter "DTx") using VR and AI technologies. Logo: https://kyodonewsprwire.jp/img/202103313079-O1-CAsOT26u

2021-04-01 16:00 1713

Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib

* Linperlisib provides significant clinical improvement in the treatment for patients with relapsed and/or refractory follicular lymphoma * Linperlisib has a differentiated and well manageable safety profile SHANGHAI ,March 31, 2021 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Y...

2021-04-01 14:09 1797

Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia

-  Zdravlje is a leading pharmaceutical manufacturer which supplies more than 35 countries around the world    -  The Company has a 65+ year track record in supplying high quality pharmaceutical products across oral solid and liquid forms -  Zdravlje represents a solid foundation upon which a le...

2021-04-01 13:00 5379

First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischemic stroke in Asia Pacific

SINGAPORE, April 1, 2021 /PRNewswire/ -- A recent study published in the Journal of Stroke  (JOS)  has found that in the treatment of acute ischemic stroke, achieving complete or near complete reperfusion after a single attempt with mechanical ...

2021-04-01 11:15 6632

Alfasigma: It's Vein Week from 5th to 11th of April

v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented inDUBAI during the EXPO An innovative geo-localization softw...

2021-04-01 08:35 3315

Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense

RARITAN, N.J., April 1, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play IVD companies, today announced that through its continued partnership with the Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Def...

2021-04-01 08:03 2022

Increased Virtual Learning Impacts Children's Vision

Expert panel on vision and health highlights the effects of screen-based learning on children's vision one year into the pandemic DALLAS, April 1, 2021 /PRNewswire/ -- The Vision Impact Institute recently convened experts in children's vision and health todiscuss the implications of digital lear...

2021-04-01 04:45 1971

Iconovo signs agreement with ISR for the development of inhaled covid-19 vaccine

STOCKHOLM, April 1, 2021 /PRNewswire/ -- Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has signed an agreement with the immunotherapy company Immune System Regulation AB (ISR), an affiliate to ISR Immune System Regulation Holding...

2021-04-01 03:19 1432
1 ... 612613614615616617618 ... 644

Week's Top Stories